Keyphrases
Cost-effectiveness
100%
Point-of-care
100%
C-reactive Protein
100%
Antibiotic Prescribing
100%
Prescribing Decisions
100%
Point-of-care CRP Testing
100%
Lower Respiratory Tract Infection
50%
Acute Cough
50%
Protein Testing
50%
Quality-adjusted Life Years
33%
Symptom Severity
33%
Health Care Services
16%
Sweden
16%
Comorbidity
16%
Patient Characteristics
16%
Patient Outcomes
16%
Presentation Management
16%
Recovery Time
16%
Diagnostic Interventions
16%
EQ-5D
16%
Health-related Quality of Life
16%
Diagnostic Tool
16%
Life-years Gained
16%
Primary Care Setting
16%
Norway
16%
POC Diagnostics
16%
QALYs Gained
16%
Willingness-to-pay Threshold
16%
Self-reported Symptoms
16%
Antibiotic Use
16%
Cost Outcomes
16%
Inflammatory Biomarkers
16%
Hierarchical Regression
16%
Regression Data
16%
Medicine and Dentistry
Health Care Cost
100%
Cost-Effectiveness Analysis
100%
C Reactive Protein
100%
Coughing
50%
Quality Adjusted Life Year
50%
Lower Respiratory Tract Infection
50%
Primary Health Care
16%
Comorbidity
16%
Clinician
16%
Biological Marker
16%
Quality of Life
16%
Observational Study
16%
Health Service
16%
Patient Characteristics
16%
Nursing and Health Professions
Cost Effectiveness Analysis
100%
C Reactive Protein
100%
Coughing
50%
Quality Adjusted Life Year
50%
Lower Respiratory Tract Infection
50%
Primary Medical Care
16%
Inflammation
16%
Comorbidity
16%
Quality of Life
16%
Treatment Outcome
16%
Biological Marker
16%
Health Care
16%
Pharmacology, Toxicology and Pharmaceutical Science
C Reactive Protein
100%
Coughing
50%
Lower Respiratory Tract Infection
50%
Observational Study
16%
Biological Marker
16%
Inflammation
16%
Comorbidity
16%